by on 2 hours ago
Four not-for-profit health systems last week announced they were taking on big pharma by creating their own generic-drug company. But experts caution it'll take years of navigating red tape and substantial investment before the operation stands a chance at lowering drug prices and alleviating shortages—if it does at all. In fact, previous attempts have fallen short. "There are no new entrants to the market because it is so difficult to get into," said Michael Rea, CEO of Rx Savings Soluti...
53 views 0 likes